Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Annual Review of Pharmacology and Toxicology|July 25, 2019
Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium ChannelsBrandon M Brown, Heesung Shim, Palle Christophersen, et al.
Frontiers in Pharmacology|October 17, 2019
The Trials and Tribulations of Structure Assisted Design of KCa Channel ActivatorsHeesung Shim, Brandon M Brown, Latika Singh, et al.
Journal of Chemical Information and Modeling|April 21, 2022
Pose Classification Using Three-Dimensional Atomic Structure-Based Neural Networks Applied to Ion Channel-Ligand DockingHeesung Shim, Hyojin Kim, Jonathan E Allen, et al.
Current Neuropharmacology|July 6, 2017
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for GlioblastomaBrandon M Brown, Brandon Pressley, Heike Wulff
F1000Research|February 14, 2019
Recent advances in our understanding of the structure and function of more unusual cation channelsBrandon M Brown, Hai M Nguyen, Heike Wulff
Molecular Pharmacology|March 11, 2025
6,7-Dichloro-1H-indole-2,3-dione-3-oxime functions as a superagonist for the intermediate-conductance Ca2+-activated K+ channel KCa3.1Joshua A Nasburg, Kyle C Rouen, Connor J Dietrich, et al.
Assay and Drug Development Technologies|December 20, 2013
Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activatorsDavid Paul Jenkins, Weifeng Yu, Brandon M Brown, et al.
Expert Opinion on Therapeutic Patents|October 20, 2010
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840Heike Wulff
Pageof 22